www.fdanews.com/articles/199786-precision-biomonitorings-covid-19-test-cleared-in-europe
Precision Biomonitoring’s COVID-19 Test Cleared in Europe
October 30, 2020
Canadian devicemaker Precision Biomonitoring has received a CE mark for its Triplelock SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) diagnostic test.
The Triplelock test and its reagents are freeze-dried so they don’t require cold-chain shipping and can run at room temperature.
The product includes 96 pre-loaded tests and is compatible with most laboratory instruments, the Guelph, Ontario-based company said.